NO20006079D0 - En stabilisert antihistaminsirup inneholdende aminopolykarboksylsyre som stabilisator - Google Patents

En stabilisert antihistaminsirup inneholdende aminopolykarboksylsyre som stabilisator

Info

Publication number
NO20006079D0
NO20006079D0 NO20006079A NO20006079A NO20006079D0 NO 20006079 D0 NO20006079 D0 NO 20006079D0 NO 20006079 A NO20006079 A NO 20006079A NO 20006079 A NO20006079 A NO 20006079A NO 20006079 D0 NO20006079 D0 NO 20006079D0
Authority
NO
Norway
Prior art keywords
stabilizer
stabilized
aminopolycarboxylic acid
syrup containing
antihistamine syrup
Prior art date
Application number
NO20006079A
Other languages
English (en)
Other versions
NO20006079L (no
NO329124B1 (no
Inventor
Farah J Munayyer
Frank Guazzo
Elliot I Stupak
Imtiaz A Chaudry
Joel A Sequeira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22209512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20006079(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20006079D0 publication Critical patent/NO20006079D0/no
Publication of NO20006079L publication Critical patent/NO20006079L/no
Publication of NO329124B1 publication Critical patent/NO329124B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20006079A 1998-06-01 2000-11-30 Sirupformulering inneholdende et antihistamin og en aminopolykarboksylsyre NO329124B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/088,128 US6132758A (en) 1998-06-01 1998-06-01 Stabilized antihistamine syrup
PCT/US1999/010469 WO1999062516A1 (en) 1998-06-01 1999-05-27 A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer

Publications (3)

Publication Number Publication Date
NO20006079D0 true NO20006079D0 (no) 2000-11-30
NO20006079L NO20006079L (no) 2000-11-30
NO329124B1 NO329124B1 (no) 2010-08-30

Family

ID=22209512

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006079A NO329124B1 (no) 1998-06-01 2000-11-30 Sirupformulering inneholdende et antihistamin og en aminopolykarboksylsyre

Country Status (29)

Country Link
US (4) US6132758A (no)
EP (1) EP1082117B1 (no)
JP (2) JP4166948B2 (no)
AR (1) AR019147A1 (no)
AT (1) ATE257705T1 (no)
AU (1) AU754469B2 (no)
CA (1) CA2333528C (no)
CO (1) CO5011119A1 (no)
CR (1) CR6035A (no)
DE (1) DE69914192T2 (no)
DK (1) DK1082117T3 (no)
EG (1) EG23908A (no)
ES (1) ES2211192T3 (no)
GC (1) GC0000330A (no)
GT (2) GT199900072AA (no)
HN (1) HN1999000081A (no)
JO (1) JO2099B1 (no)
ME (1) ME01664B (no)
MY (1) MY123325A (no)
NL (1) NL1012191C2 (no)
NO (1) NO329124B1 (no)
NZ (1) NZ508037A (no)
PA (1) PA8474201A1 (no)
PE (1) PE20000565A1 (no)
PT (1) PT1082117E (no)
RS (1) RS49609B (no)
SV (1) SV1999000068A (no)
TW (1) TW589197B (no)
WO (1) WO1999062516A1 (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
AU2277101A (en) * 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
CA2393837A1 (en) * 1999-12-21 2001-06-28 Schering Corporation Use of desloratadine for treating allergic and inflammatory conditions in pediatric patients
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
JP5592042B2 (ja) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
US20030216423A1 (en) * 2000-05-24 2003-11-20 Sergio Ulloa Stable liquid and solid formulations
AU2001264806A1 (en) * 2000-05-25 2001-12-03 Schering Corporation Stable liquid and solid formulations
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
IN192160B (no) * 2000-07-17 2004-02-28 Ranbaxy Lab
WO2002010756A2 (en) * 2000-08-02 2002-02-07 Malope Company Limited Diagnosis and treatment of non-ulcer dyspepsia based on hypothalamic-pituitary-adrenal axis abnormality
US6720002B2 (en) 2001-07-20 2004-04-13 R.P. Scherer Technologies, Inc. Antihistamine formulations for soft capsule dosage forms
AR037131A1 (es) 2001-10-31 2004-10-20 Schering Corp Formulaciones de jarabe de ribavirina
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US20040101563A1 (en) * 2002-07-18 2004-05-27 Kundu Subhas C. Storage stable antihistaminic syrup formulations
US20100092562A1 (en) * 2002-11-26 2010-04-15 Hollenbeck R Gary Sustained-release drug delivery compositions and methods
US6635654B1 (en) 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
JO2735B1 (en) 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
WO2004108700A1 (en) * 2003-03-12 2004-12-16 Teva Gyogyszergyar Reszvenytarsasag Processes for preparation of polymorphic forms of desloratadine
JP3881640B2 (ja) * 2003-08-08 2007-02-14 塩野義製薬株式会社 ロラタジンを含むドライシロップ剤
US20050069590A1 (en) 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
WO2005076829A2 (en) * 2004-02-05 2005-08-25 Taro Pharmaceuticals U.S.A., Inc. Stable loratadine spill resistant formulation
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
GB0417909D0 (en) * 2004-08-11 2004-09-15 Novartis Consumer Health Sa Drop preparations
US20060093631A1 (en) * 2004-10-29 2006-05-04 Buehler Gail K Dye-free pharmaceutical suspensions and related methods
US20070009558A1 (en) * 2004-12-22 2007-01-11 David Harris Sugar-free storage-stable antihistaminic syrups
CA2591706A1 (en) * 2004-12-22 2006-06-29 Schering Corporation Pharmaceutical formulations
US20060205752A1 (en) * 2005-03-14 2006-09-14 Keith Whitehead Stabilized hydrocodone pharmaceutical compositions with ethylenediaminetetraacetic acid
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
AU2005333081B2 (en) * 2005-06-17 2010-06-24 Aft Pharmaceuticals Limited Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
DOP2006000274A (es) 2005-12-14 2007-10-15 Sanofi Aventis Us Llc Formulación de suspensión de fexofenadina
WO2007143382A2 (en) * 2006-06-07 2007-12-13 Morton Grove Pharmaceuticals, Inc. Oral liquid loratadine formulations and methods
AU2007269835A1 (en) * 2006-06-29 2008-01-10 Schering Corporation Sugar-free storage-stable antihistaminic syrups
US20080014275A1 (en) * 2006-07-13 2008-01-17 Buehler Gail K Pharmaceutical suspensions and related methods
US20080207593A1 (en) * 2007-02-28 2008-08-28 Collegium Pharmaceutical, Inc. Antihistamine Combination
ES2610603T3 (es) * 2007-06-08 2017-04-28 The Procter & Gamble Company Composiciones que contienen miel natural y método de preparación
US20090082385A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched desloratidine
CA2690490C (en) 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
JP5752578B2 (ja) * 2011-12-09 2015-07-22 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
BR102012030828A2 (pt) 2012-12-03 2014-09-16 Ems Sa Composição farmacêutica compreendendo desloratadina e prednisolona e seu uso
CN104784110A (zh) * 2015-03-13 2015-07-22 浙江凯润制药有限公司 一种地氯雷他定糖浆制剂及其制备方法
RU2019109695A (ru) 2016-09-26 2020-10-26 Дзе Проктер Энд Гэмбл Компани Лекарственная форма для пролонгированного ослабления симптомов
CN109498569A (zh) * 2018-12-21 2019-03-22 湖北康源药业有限公司 一种氯雷他定糖浆及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501205A (ja) * 1984-02-15 1986-06-19 シェリング・コ−ポレ−ション ８↓−クロル↓−６，１１↓−ジヒドロ↓−１１↓−（４↓−ピペリジリデン）↓−５Ｈ↓−ベンゾ〔５，６〕シクロヘプタ〔１，２−ｂ〕ピリジンおよびその塩、これらの化合物の製造方法、ならびにこれらの化合物を含有する医薬組成物
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
US4975426A (en) * 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
NZ256346A (en) 1992-10-09 1997-04-24 Procter & Gamble Medicaments containing 3-l-menthoxypropane-1,2-diol for treating cold symptoms
CA2121435C (en) * 1993-04-16 2002-01-22 Sheila M. Ratnaraj Aqueous pharmaceutical suspension and process for preparation thereof
US5458879A (en) 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
JPH09124484A (ja) 1995-10-27 1997-05-13 Schering Purau Kk 点眼剤
US5912007A (en) * 1996-02-29 1999-06-15 Warner-Lambert Company Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
PE11399A1 (es) * 1996-10-31 1999-02-09 Schering Corp Combinacion de loratadina y un descongestionante para el tratamiento del asma
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
US5939426A (en) * 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup

Also Published As

Publication number Publication date
WO1999062516A1 (en) 1999-12-09
PA8474201A1 (es) 2001-07-31
GT199900072A (es) 2000-11-16
AU754469B2 (en) 2002-11-14
DE69914192T2 (de) 2004-10-21
US6939550B2 (en) 2005-09-06
JP4166948B2 (ja) 2008-10-15
NL1012191C2 (nl) 2000-01-04
NZ508037A (en) 2002-11-26
PE20000565A1 (es) 2000-07-05
TW589197B (en) 2004-06-01
RS49609B (sr) 2007-06-04
CA2333528A1 (en) 1999-12-09
US6514520B2 (en) 2003-02-04
ES2211192T3 (es) 2004-07-01
US20050261280A1 (en) 2005-11-24
MY123325A (en) 2006-05-31
ME01664B (me) 2007-06-04
JP2002516860A (ja) 2002-06-11
GT199900072AA (es) 2000-11-16
CR6035A (es) 2008-11-26
CO5011119A1 (es) 2001-02-28
JP2005015485A (ja) 2005-01-20
EP1082117B1 (en) 2004-01-14
NO20006079L (no) 2000-11-30
JO2099B1 (en) 2000-05-21
HN1999000081A (es) 1999-08-23
YU23599A (sh) 2001-07-10
ATE257705T1 (de) 2004-01-15
AU4308599A (en) 1999-12-20
SV1999000068A (es) 2000-06-23
CA2333528C (en) 2002-07-02
AR019147A1 (es) 2001-12-26
EG23908A (en) 2007-12-30
NO329124B1 (no) 2010-08-30
US20030152595A1 (en) 2003-08-14
DK1082117T3 (da) 2004-05-03
NL1012191A1 (nl) 1999-12-03
PT1082117E (pt) 2004-05-31
DE69914192D1 (de) 2004-02-19
GC0000330A (en) 2007-03-31
EP1082117A1 (en) 2001-03-14
US6132758A (en) 2000-10-17
US20020132805A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
DK1082117T3 (da) Stabiliseret antihistaminsirup indeholdende aminopolycarboxylsyre som stabilisator
DE69907435D1 (de) (4-sulfonylamino)-tetrahydropyran-4-carbonsäure hydroxamiden
IS5714A (is) Ný 3-arýl-2-hýdroxýprópíonsýruafleiða (I)
NO20013149L (no) Piperidiner som CCR5-modulatorer
NO20004177L (no) Intervensjonsmodul for en brönn
DK1036062T3 (da) Hydroxamsyrederivater som matrix metalloprotease (MMP) inhibitorer
ATE311887T1 (de) Diphosphonsäure enthaltende zusammensetzungen
ID26978A (id) Turunan-turunan asam aminometilkarboksilat
DE69924542D1 (de) Farbbandkassette
ATE419231T1 (de) Mono-substituierte 3-propyl-gamma- aminobuttersäure
NO20013675L (no) 2,3,4,5-tetrahydro-1H-[1,4)benzodiazepin-3-hydroksamsyre som matriks-metalloproteinase-inhibitorer
NO20014602D0 (no) Skum som inneholder et fyllstoff
DE69812371D1 (de) Phenyllacrylsäurederivate enthaltende fungizide kombinationen
ZA988062B (en) 4-hydroxyquinoline-3-carboxylic acid derivatives as light stabilizers
DK1147080T3 (da) Alkynylholdige hydroxamsyreforbindelser som TACE-inhibitorer
ITMI20001423A0 (it) Struttura di connessione per connettori a coppie
DK1165734T3 (da) Stabile, vandige sammensætninger, som indeholder en silicium-forbindelse
DK1013639T3 (da) Arylcarboxylsyre og tetrazolderivater, som indeholder en carbamoyloxyenhed
DE69911586D1 (de) Optisch aktive epoxyverbindungen
FR2776819B1 (fr) Dram a structure rapide
DE60038751D1 (de) Farbband
DE60008338D1 (de) Farbbandkassette
DK1137667T3 (da) GLP-1-analoger
AU2434099A (en) Bleach stabiliser including fatty acid salts
ATE250572T1 (de) Aromatische sulphonyl-alpha-hydroxy- hydroxamsäureverbindungen

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP AND DOHME CORP

Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY, US

MK1K Patent expired